Friday, 26 August 2016 00:00

Confirmed Falsified Quinine Sulphate 300mg In Circulation

Rate this item
(3 votes)

The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified of the circulation of two confirmed falsified Quinine Sulphate 300mg tablet versions in Cameroon and the Democratic Republic of Congo.  The products have been found to contain zero active pharmaceutical ingredients.

Quinine Sulphate is an anti-malaria drug used for the treatment of Plasmodium falciparum Malaria. These falsified products were first discovered by a local NGO on failing field screening. They were submitted to a WHO pre-qualified Quality Assurance Laboratory and subsequent analysis from the laboratory showed neither of the products contained any of the stated active ingredients.

The details of the falsified products are;

Product 1 Product 2

Product Name: Quinine Sulphate 300mg

Manufacturer: Novadina Pharmaceutical Ltd,  

                            London, United Kingdom

Number of tablets per container: 1000

Batch Number: 10H05

Date of Manufacture:  09/2014

Expiry date: 09/2018

Product Name: Quinine Sulphate 300mg

Manufacturer: CAD Pharm, India

Number of tablets per container: 100

Batch Number: F4387

Date of Manufacture:  12/14

Expiry date: 11/18

NAFDAC implores importers, distributors, retailers and the general public to ensure vigilance and avoid the purchase of the confirmed falsified products.

 All distributors, retailers and members of the public with these falsified products should submit products to the nearest NAFDAC office for distruction.

NAFDAC...........Safeguarding the health of the Nation!!!

Read 10004 times Last modified on Monday, 29 August 2016 08:38
Login to post comments
  • LATEST NEWS AND EVENTS
  • RECALLS & ALERTS
  • REPORT A PROBLEM
View More

• Report Adverse Drug Reaction                    • Send Us a Complaint

• Report Suspected Criminal Activity           • Send Us a Feedback

  • CONFERENCE PAPERS
  • FEATURED PUBLICATIONS